NCT00408330

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.

Detailed description

To test the efficacy and safety of azelaic acid 15% gel in the treatment of seborrheic dermatitis of the face

Conditions

• Seborrheic Dermatitis on the Face

Interventions

Type	Name	Description
DRUG	Azelaic Acid 15% Gel	15% gel, topically applied daily for six weeks
DRUG	Inactive 15% gel base	placebo, topically applied daily for six weeks

Timeline

• Start date: 2006-12-01
• Primary completion: 2007-03-01
• Completion: 2007-03-01
• First posted: 2006-12-06
• Last updated: 2023-06-09

Locations

4 sites across 1 country: Germany